Abstract Details

Title Amyotrophic Lateral Sclerosis Mortality Variation among Different Racial/Ethnic Groups in United States

Topic Anterior Horn

Presentation(s) P05 - (-)

Poster/Presentation
Number 073

Objective

Background BACKGROUND: The racial/ethnic mortality differences amyotrophic lateral sclerosis (ALS) in United States. are not well studied.

Design/Methods DESIGN/METHODS: We identified all mortalities related to ALS using the ICD-10 code G12. from Multiple Cause of Death data files from 2000 to 2009. The population census was used to derive the incidence of ALS death for each racial (whites, African Americans, and others) group. We also calculated the annual percent change (APC) in incidence rates from 2000-2009.

Results RESULTS: A total of 57942 ALS deaths were reported by during 2000 to 2009. The Annual number of ALS deaths varied between a minimum of 5398 (2001) and a maximum of 6241 on 2008. The incidence rates of ALS death were highest among white Americans: the average incidence rate was 4.9/100.000 (minimum 4.7/100.000 on 2005, maximum 5.1/100.000 in 2003), followed by African Americans with average incidence rate of 2.2/100.000 and other ethnic groups with average incidence 2/100.000. Other ethnic groups have a higher average APC (4.15%) compared to white ((-0.01%) and African Americans (0.-14%). In all ethnic groups the death rate was higher in male compared to female. Average APC was higher in female in African Americans and in other ethnic groups.

Conclusions CONCLUSIONS: Although the death rate from ALS was higher in white group compared to African Americans and other ethnic groups, its APC was the lowest among the studied ethnic groups. , Further studies are required to understand the underlying reasons for this disparity.

Authors/Disclosures
PRESENTER	No disclosure on file
Hamza I. Maqsood, MD (Dept of Neurology)	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Nizar Souayah, MD, FAAN (NJMS)	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Frank Bennett, PhD	No disclosure on file

��ɫ��

��ɫ��